EirGenix (TPE:6589) Other Current Payables: NT$408 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6589 EirGenix Inc TPE:6589
58 GF Score
Price NT$47.30
GF Value NT$93.04
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is EirGenix Other Current Payables?

EirGenix TPE:6589 +1.50% 58 Other Current Payables is NT$408 Mil as of Dec. 2025. GuruFocus rates TPE:6589 with a GF Score™ of 58/100 and a GF Value™ of NT$93.04 (Possible Value Trap). The stock has 6 warning signs investors should review.

EirGenix's Other Current Payables for the quarter that ended in Dec. 2025 was NT$408 Mil.

EirGenix's quarterly Other Current Payables declined from Jun. 2025 (NT$380 Mil) to Sep. 2025 (NT$348 Mil) but then increased from Sep. 2025 (NT$348 Mil) to Dec. 2025 (NT$408 Mil).

EirGenix's annual Other Current Payables increased from Dec. 2023 (NT$538 Mil) to Dec. 2024 (NT$576 Mil) but then declined from Dec. 2024 (NT$576 Mil) to Dec. 2025 (NT$408 Mil).

EirGenix Other Current Payables Related Terms

EirGenix Other Current Payables Historical Data

* Premium members only.

The historical data trend for EirGenix's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EirGenix Other Current Payables Chart

EirGenix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 240.41 415.12 538.29 576.05 407.57

EirGenix Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 576.05 438.29 379.70 348.32 407.57
TPE:6589
58GF Score
EirGenix Inc TPE:6589
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EirGenix Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of NT$408 Mil mean?
EirGenix (TPE:6589) has a Other Current Payables of NT$408 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on EirGenix and its competitors.
Is EirGenix's Other Current Payables too high?
EirGenix's current Other Current Payables is NT$408 Mil. Overall, EirGenix has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EirGenix's Other Current Payables compare to VRTX and REGN?
EirGenix's Other Current Payables of NT$408 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on EirGenix and its competitors. EirGenix's current Other Current Payables is NT$408 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EirGenix stock overvalued right now?
Based on GuruFocus' analysis, EirGenix (TPE:6589) is currently considered Possible Value Trap. The stock's GF Value™ is NT$93.04, compared to a current price of NT$47.30 — trading 49.2% below its estimated fair value. The current Other Current Payables is NT$408 Mil. EirGenix's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For EirGenix (TPE:6589), the current Other Current Payables is NT$408 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EirGenix (TPE:6589) Overvalued in 2026?

Based on GuruFocus' analysis, EirGenix stock appears to be undervalued. The current stock price of NT$47.30 is trading 49.2% below its estimated GF Value™ of NT$93.04. GuruFocus considers EirGenix to be Possible Value Trap.

Key valuation signals for TPE:6589:

  • Other Current Payables: NT$408 Mil
  • GF Value™: NT$93.04 vs. price of NT$47.30 (49.2% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the TPE:6589 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EirGenix Business Description

Address No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
EirGenix Inc is engaged in the research and development of biosimilars and new drugs, as well as biopharmaceutical contract development and manufacturing services, which included cell line construction platforms, process development platforms, analytical science and protein identification. Its products include CRM197 CARRIER PROTEIN, PRODUCT PIPELINE, COVID-19 ANTIGEN RAPID TEST. The revenue is derived from biopharmaceutical contract development and manufacturing services, sales of authorization and cooperative development, and sales of goods. Geographically, it operates in Japan, Taiwan, USA and Canada, Mainland China, Hong Kong, and Macao, and Europe, Others.
58GF Score

Get the complete analysis for TPE:6589

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$47.30
Price
NT$93.04
GF Value